NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,000 | -65.4% | 13,250 | -11.0% | 0.00% | -100.0% |
| Q2 2023 | $617,977 | -53.9% | 14,888 | -33.2% | 0.00% | -50.0% |
| Q1 2023 | $1,340,509 | -77.2% | 22,294 | -72.2% | 0.00% | -71.4% |
| Q4 2022 | $5,886,148 | +9.3% | 80,249 | +13.2% | 0.01% | 0.0% |
| Q3 2022 | $5,384,000 | +59.0% | 70,863 | +45.4% | 0.01% | +75.0% |
| Q2 2022 | $3,386,000 | -54.1% | 48,721 | -45.3% | 0.00% | -33.3% |
| Q1 2022 | $7,384,000 | -75.6% | 89,120 | -77.9% | 0.01% | -76.0% |
| Q4 2021 | $30,288,000 | -61.1% | 403,415 | -39.8% | 0.02% | -62.1% |
| Q3 2021 | $77,895,000 | -61.5% | 670,527 | -26.5% | 0.07% | -60.2% |
| Q2 2021 | $202,343,000 | +117.7% | 912,190 | +29.7% | 0.17% | +26.7% |
| Q1 2021 | $92,967,000 | -54.9% | 703,334 | -41.0% | 0.13% | -56.5% |
| Q4 2020 | $206,177,000 | +22.3% | 1,191,496 | -21.3% | 0.30% | +5.6% |
| Q3 2020 | $168,607,000 | +202.2% | 1,514,755 | +61.0% | 0.28% | +196.9% |
| Q2 2020 | $55,796,000 | -36.6% | 940,902 | -28.0% | 0.10% | -47.0% |
| Q1 2020 | $87,976,000 | +6.0% | 1,306,445 | +32.6% | 0.18% | +52.1% |
| Q4 2019 | $83,002,000 | +14.0% | 984,958 | +1.2% | 0.12% | -2.5% |
| Q3 2019 | $72,812,000 | -70.7% | 973,679 | -75.2% | 0.12% | -13.5% |
| Q2 2019 | $248,346,000 | +343.5% | 3,927,660 | +237.9% | 0.14% | +46.9% |
| Q1 2019 | $55,997,000 | +36.5% | 1,162,494 | -5.1% | 0.10% | +21.5% |
| Q4 2018 | $41,029,000 | -29.1% | 1,225,475 | +11.0% | 0.08% | -16.0% |
| Q3 2018 | $57,856,000 | +216.4% | 1,104,117 | +89.0% | 0.09% | +193.8% |
| Q2 2018 | $18,283,000 | +980.6% | 584,129 | +652.7% | 0.03% | +966.7% |
| Q1 2018 | $1,692,000 | +19.6% | 77,603 | +10.8% | 0.00% | 0.0% |
| Q4 2017 | $1,415,000 | +41.2% | 70,066 | +38.9% | 0.00% | +50.0% |
| Q3 2017 | $1,002,000 | -14.0% | 50,460 | -25.1% | 0.00% | 0.0% |
| Q2 2017 | $1,165,000 | +50.7% | 67,342 | -29.4% | 0.00% | +100.0% |
| Q1 2017 | $773,000 | +0.4% | 95,377 | -2.8% | 0.00% | 0.0% |
| Q4 2016 | $770,000 | +8.8% | 98,087 | +18.4% | 0.00% | 0.0% |
| Q3 2016 | $708,000 | -59.9% | 82,869 | -45.2% | 0.00% | -50.0% |
| Q2 2016 | $1,766,000 | – | 151,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |